Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Dose of tirapazamine for combination chemotherapy studies selected from phase I data

June 25, 1997

Gemcitabine vs. cisplatin + etoposide for stage III-IV NSCLC

June 24, 1997

Penclomedine: phase I results in patients with solid tumors

June 24, 1997

PBR ligand-melphalan conjugate with promise for brain tumors

June 24, 1997

Medac launches Oncaspar in Germany

June 23, 1997

Taxotere now available in Japan for non-small cell lung and breast cancers

June 23, 1997

Matrix initiates phase II trial of IntraDose in primary liver cancer

June 23, 1997

Agouron's IND for anticancer agent approved

June 20, 1997

Sugen receives notices of allowance covering SU-101 for solid tumor treatment

June 19, 1997

NeoPharm begins phase I/II trial for liposome-encapsulated doxorubicin

June 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...